• Tropisetron Hydrochloride: Selective 5-HT3 Receptor Antagoni

  2026-05-25

  Tropisetron Hydrochloride is a potent, selective 5-HT3 receptor antagonist with an IC50 of 70.1 nM, offering reproducible results in serotonin receptor signaling research. It also acts as an α7-nicotinic receptor agonist and is widely used to interrogate neuropharmacology and transporter function. High solubility and validated purity make it a gold-standard research tool.

• Macrophage EP4 Loss Drives Atherosclerosis via CD36 and M1 S

  2026-05-25

  This study reveals that deficiency of the prostaglandin E2 receptor EP4 in macrophages accelerates atherosclerosis by enhancing CD36-mediated lipid uptake and promoting M1 polarization. The findings clarify the mechanistic role of EP4 in plaque progression and stability, suggesting new avenues for targeted cardiovascular therapies.

• Microfluidic Peptide/RNA Complexes Enable Nebulised mRNA Del

  2026-05-24

  The referenced study demonstrates a robust method for preparing peptide/RNA complexes via microfluidic mixing, enabling efficient pulmonary delivery of mRNA and siRNA through nebulisation. This innovation preserves complex integrity and transfection efficiency after aerosolisation, supporting next-generation non-viral RNA therapeutics for lung disease.

• BML-277 and Chk2 Inhibition: A Strategic Pivot in DNA Damage

  2026-05-23

  This thought-leadership article explores how BML-277, a potent and selective Chk2 inhibitor from APExBIO, advances translational research in DNA damage response, radioprotection of T-cells, and genome integrity. By integrating mechanistic insights from recent literature—including cGAS regulation and L1 retrotransposition suppression—this piece provides strategic guidance on experimental design, protocol optimization, and the evolving clinical relevance of Chk2 targeting.

• CasKAS: Genome-wide Mapping of CRISPR Specificity via ssDNA

  2026-05-22

  The CasKAS assay introduces a rapid, cost-effective approach for profiling genome-wide specificity of both Cas9 and dCas9 using single-stranded DNA mapping. This technique advances the field by directly detecting off-target CRISPR binding and cleavage, providing researchers with a versatile alternative to labor-intensive or expensive prior methods.

• Ibotenic Acid: Precision Neural Circuit Lesioning in Pain Mo

  2026-05-22

  Explore how Ibotenic acid, a selective NMDA receptor agonist, enables reproducible and targeted neural circuit lesioning in animal models of neurodegenerative disorders. This article uniquely examines protocol strategies, assay implications, and recent innovations for advanced neuroscience research.

• Ibrexafungerp (MK 3118): Advanced Antifungal Workflows & Ins

  2026-05-21

  Ibrexafungerp (MK 3118) stands out as a potent oral antifungal with proven activity against multidrug-resistant Candida, including fluconazole- and echinocandin-resistant isolates. This article delivers actionable workflows, comparative advantages, and troubleshooting strategies for research labs working on invasive candidiasis and beyond.

• Cellular Senescence Gene Signature Predicts Cholangiocarcino

  2026-05-21

  This study introduces a machine learning-derived gene signature based on cellular senescence pathways to predict prognosis and drug sensitivity in cholangiocarcinoma. The approach offers a robust prognostic tool with high accuracy, providing new insights for stratifying patients and guiding therapeutic decisions.

• Degarelix Acetate: Mechanistic Precision for Translational E

  2026-05-20

  This thought-leadership article explores the mechanistic and translational advantages of Degarelix acetate, a highly selective GnRH receptor antagonist, in hormone pathway and prostate cancer research. Drawing on recent structural insights, competitive landscape analysis, and validated protocols, we provide strategic guidance for translational researchers seeking reproducibility and clinical relevance in endocrine and oncology models. The article builds on existing literature, including a landmark synthesis study, and situates APExBIO’s Degarelix acetate as an optimal tool for advancing mechanistic discovery and translational impact.

• Crizotinib Hydrochloride in Complex Tumor Microenvironment R

  2026-05-20

  Explore how Crizotinib hydrochloride, a leading ALK kinase inhibitor, enables precise dissection of tumor–stroma interactions in patient-derived assembloid models. This article uniquely focuses on optimizing preclinical assay design and translational applications in cancer biology research.

• Direct Mouse Genotyping Kit Plus: Fast, Purification-Free PC

  2026-05-19

  The Direct Mouse Genotyping Kit Plus streamlines mouse DNA extraction and PCR, enabling rapid, reliable genetic assays without time-consuming purification. Its optimized protocol, featuring a PCR master mix with dye reagents, delivers consistent results for routine genotyping, transgene detection, and knockout validation. Discover how this APExBIO kit redefines experimental efficiency and troubleshooting for modern mouse colony management.

• Temafloxacin in Advanced Infection Biology: Mechanisms and P

  2026-05-19

  Explore the multifaceted scientific applications of Temafloxacin, a fluoroquinolone broad-spectrum antibacterial agent. This in-depth guide reveals mechanistic insights, advanced assay strategies, and differentiates its research value beyond routine protocols.

• Amikacin Sulfate: Applied Workflows for Targeted Infection M

  2026-05-18

  Amikacin Sulfate empowers precise, reproducible in vitro and in vivo modeling of non-tuberculous mycobacterial infections, with advanced uptake and delivery workflows. APExBIO’s high-purity formulation enables researchers to dissect intracellular pharmacokinetics and optimize therapeutic efficacy—while minimizing toxicity risk.

• Iron Homeostasis Modulates PS-Nanoplastics-Induced Lung Fibr

  2026-05-18

  This study demonstrates that polystyrene nanoplastics (PS-NPs) promote pulmonary fibroblast proliferation and activation via disruption of iron homeostasis, highlighting intercellular crosstalk as a mechanistic driver. Targeting iron accumulation significantly reduced fibroblast activation, offering mechanistic insight for pulmonary fibrosis pathogenesis and potential intervention points.

• Rotenone in Translational Research: Mechanistic Leverage and

  2026-05-17

  This thought-leadership article provides translational researchers with an integrated perspective on the use of Rotenone as a mitochondrial Complex I inhibitor. By bridging mechanistic insight, experimental protocols, and strategic application, we examine how Rotenone from APExBIO enables high-fidelity modeling of mitochondrial dysfunction across neurodegenerative and metabolic disease research, with particular focus on its roles in apoptosis, autophagy, and disease-specific pathway interrogation. We uniquely connect recent findings on NLRP3-mediated cell death in diabetic cardiomyopathy to Rotenone’s utility, highlighting both the opportunities and boundaries of such cross-domain translational strategies.

15103 records 1/1007 page Next 12345 下5页 Last page